Lynn is a registered patent agent who focuses on US and international patent prosecution. Her practice includes drafting and prosecuting patent applications and assisting in inter partes reviews and due diligence matters. She has experience in the areas of molecular biology, neuroscience, immunology, virology, microbiology, cell biology, biotechnology, and cancer biology.
Lynn has published papers on gene therapy, HIV, cancer, and neurological disease in a number of publications, including the Journal of Neuroinflammation, Experimental Hematology, Molecular and Cellular Neuroscience, and the Journal of Immunology. Lynn was a post-doctoral research associate at the University of Rochester, where she developed a method for cell-specific targeting of plasmid DNA to alveolar epithelial type I cells for use in gene therapy and analyzed how a particular drug killed non-Hodgkin lymphoma cells. While earning her master’s and PhD at the university, she wrote a thesis relating to neurotrophin-induced cell survival mechanisms in neuronal and non-neuronal cell types.
- University of Rochester (PhD, Microbiology and Immunology)
- University of Rochester (MS, Microbiology and Immunology)
- University of Rochester (BA, Biology, cum laude)